# OnCo record rejuv-paed-transition-to-adult-care (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-paed-transition-to-adult-care/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-paed-transition-to-adult-care" ;
  schema:name "The handover from children's to adult services, where follow-up falls away"@en ;
  schema:description "This is where survivorship care is lost. Of 8,522 adult survivors asked, 88.8 per cent had seen a doctor in the previous two years but only 17.8 per cent had received care that addressed their cancer history with risk advice or screening. Among those who should have had an echocardiogram, 28.2 per cent had; among those due a mammogram, 40.8 per cent had."@en ;
  schema:url <https://onco.cc/technologies/rejuv-paed-transition-to-adult-care/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cancer_survivor> ;
  schema:citation <https://doi.org/10.1200/JCO.2008.16.9607>, <https://doi.org/10.1007/s11764-015-0480-9>, <https://doi.org/10.1634/theoncologist.2018-0103>, <https://doi.org/10.1186/s12913-025-13363-8> ;
  onco:status "emerging" ;
  onco:tag "rejuvenation", "survivorship", "paediatric", "late-effects", "evidence:moderate" ;
  onco:related <https://onco.cc/trials/ccss/>, <https://onco.cc/collections/pancaresurfup/>, <https://onco.cc/ideas/idea-acc-aya-survivorship-passport/>, <https://onco.cc/ideas/idea-acc-auto-generated-survivorship-plans/>, <https://onco.cc/ideas/idea-moon-survivor-lifelong-care-model/> ;
  onco:cancers <https://onco.cc/cancers/childhood-cancers/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/medulloblastoma/>, <https://onco.cc/cancers/neuroblastoma/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/rejuv-paed-cog-ltfu-guidelines/>, <https://onco.cc/technologies/rejuv-paed-uk-long-term-follow-up/>, <https://onco.cc/technologies/rejuv-ayac-services/>, <https://onco.cc/technologies/rejuv-paed-chronic-disease-burden/> ;
  onco:terms <https://onco.cc/terms/late-effects/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-care-fragmentation/>, <https://onco.cc/bottlenecks/b-knowledge-diffusion/> .